rs548231613

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM4BP6_Very_StrongBS2

The NM_006766.5(KAT6A):​c.5040_5051delACAGCAGCCGCA​(p.Gln1681_Gln1684del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00129 in 1,597,142 control chromosomes in the GnomAD database, including 5 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00094 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 5 hom. )

Consequence

KAT6A
NM_006766.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.99

Publications

1 publications found
Variant links:
Genes affected
KAT6A (HGNC:13013): (lysine acetyltransferase 6A) This gene encodes a member of the MOZ, YBFR2, SAS2, TIP60 family of histone acetyltransferases. The protein is composed of a nuclear localization domain, a double C2H2 zinc finger domain that binds to acetylated histone tails, a histone acetyl-transferase domain, a glutamate/aspartate-rich region, and a serine- and methionine-rich transactivation domain. It is part of a complex that acetylates lysine-9 residues in histone 3, and in addition, it acts as a co-activator for several transcription factors. Allelic variants of this gene are associated with an autosomal dominant form of cognitive disability. Chromosomal translocations of this gene are associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
KAT6A Gene-Disease associations (from GenCC):
  • autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_006766.5.
BP6
Variant 8-41933168-CTGCGGCTGCTGT-C is Benign according to our data. Variant chr8-41933168-CTGCGGCTGCTGT-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 589281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 143 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KAT6ANM_006766.5 linkc.5040_5051delACAGCAGCCGCA p.Gln1681_Gln1684del disruptive_inframe_deletion Exon 17 of 17 ENST00000265713.8 NP_006757.2 Q92794A5PKX7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KAT6AENST00000265713.8 linkc.5040_5051delACAGCAGCCGCA p.Gln1681_Gln1684del disruptive_inframe_deletion Exon 17 of 17 1 NM_006766.5 ENSP00000265713.2 Q92794

Frequencies

GnomAD3 genomes
AF:
0.000942
AC:
143
AN:
151738
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000969
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00177
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000884
AC:
196
AN:
221694
AF XY:
0.000801
show subpopulations
Gnomad AFR exome
AF:
0.0000728
Gnomad AMR exome
AF:
0.000931
Gnomad ASJ exome
AF:
0.000212
Gnomad EAS exome
AF:
0.000709
Gnomad FIN exome
AF:
0.000300
Gnomad NFE exome
AF:
0.00138
Gnomad OTH exome
AF:
0.00162
GnomAD4 exome
AF:
0.00133
AC:
1918
AN:
1445286
Hom.:
5
AF XY:
0.00128
AC XY:
917
AN XY:
717976
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33296
American (AMR)
AF:
0.000991
AC:
43
AN:
43390
Ashkenazi Jewish (ASJ)
AF:
0.000271
AC:
7
AN:
25842
East Asian (EAS)
AF:
0.000254
AC:
10
AN:
39388
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
85018
European-Finnish (FIN)
AF:
0.000375
AC:
18
AN:
47970
Middle Eastern (MID)
AF:
0.000227
AC:
1
AN:
4414
European-Non Finnish (NFE)
AF:
0.00159
AC:
1754
AN:
1106148
Other (OTH)
AF:
0.00129
AC:
77
AN:
59820
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
105
211
316
422
527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000942
AC:
143
AN:
151856
Hom.:
0
Cov.:
31
AF XY:
0.00104
AC XY:
77
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.0000967
AC:
4
AN:
41382
American (AMR)
AF:
0.00105
AC:
16
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00177
AC:
120
AN:
67898
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.000941

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KAT6A: BS1 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 30, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 07, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.0
Mutation Taster
=197/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs548231613; hg19: chr8-41790686; API